The funding is intended to enable research and development (R&D) work in the field of medical technology and to accelerate the implementation of research results in new products and processes.
The orientation of the R&D projects is designed to increase competence and efficiency in the healthcare sector in Bavaria.
The funding covers the following topics and issues in particular:
- Bioinformatics methods including biosignal analysis and synthesis,
- medical imaging and image processing,
- intelligent, biomedical sensors or actuators in micro- and nanotechnology,
- laser applications and optical systems for diagnosis and therapy,
- biomedical mechatronics and robotics,
- medical technology for minimally invasive surgery and interventions,
- medical engineering design and instrumentation,
- Biomaterials, tissue engineering and implants,
- organ and orthopedic prosthetics,
- physical methods for preservation or selection procedures,
- system-relevant software for diagnosis and therapy,
- telemedicine and eHealth,
- preventive methods for geriatrics and health maintenance.
Eligible applicants are
- Companies with headquarters or branch offices in the Free State of Bavaria,
- non-university research institutions as well as state universities and institutions of state universities in Bavaria,
- other applicants with their registered office or branch office in the Free State of Bavaria who have the technical qualifications and sufficient capacity to successfully complete the tasks described in the project.
The research, development and innovation (R&D&I) projects must be carried out in close cooperation between several companies from the commercial sector or between such companies and research institutions. Several partners along the value chain are to cooperate. Preference will be given to small and medium-sized enterprises (SMEs).
The following are eligible for funding
- Personnel costs (flat rates),
- Costs for instruments and equipment,
- costs for contract research, technical knowledge and for patents acquired directly or under license from third parties, as well as costs for consulting and equivalent services used exclusively for the research and development project,
- other operating expenses (materials, supplies, etc.) incurred directly as a result of the research and development activity.
Type and scope
The funding is provided in the form of grants as part of project funding.
The aid intensity is
- Up to 50 percent of the eligible costs of the project or feasibility study in the case of industrial research,
- up to 25 percent of the eligible costs of the project or feasibility study in the case of experimental development.
In the case of collaborative projects, the aid intensity is determined for each individual beneficiary; the maximum aid intensity for the collaborative project is 50 percent. In addition, up to 15 percentage points may be granted to industrial project partners if the conditions of Article 25(6)(b) of the GBER are met.
If different project activities can be assigned to both industrial research and experimental development, the funding rate will be determined on a pro rata basis.